Learn More
  • K C Bible, Roy H. Bible, +5 authors S H Kaufmann
  • Cancer research
  • 2000
Flavopiridol, the first potent cyclin-dependent kinase inhibitor to enter clinical trials, was recently found to be cytotoxic to noncycling cells. The present studies were performed to examine the(More)